Literature DB >> 29479029

Cytogenetic, genomic, and epigenetic characterization of the HSC-3 tongue cell line with lymph node metastasis.

Ilda P Ribeiro1,2, Joana M Rodrigues1, Alexandra Mascarenhas1, Nadezda Kosyakova3, Francisco Caramelo4, Thomas Liehr3, Joana B Melo1,2, Isabel M Carreira1,2.   

Abstract

Oral carcinoma develops from squamous epithelial cells by the acquisition of multiple (epi) genetic alterations that target different genes and molecular pathways. Herein, we performed a comprehensive genomic and epigenetic characterization of the HSC-3 cell line through karyotyping, multicolor fluorescence in situ hybridization, array comparative genomic hybridization, and methylation-specific multiplex ligation-dependent probe amplification. HSC-3 turned out to be a near-triploid cell line with a modal number of 61 chromosomes. Banding and molecular cytogenetic analyses revealed that nonrandom gains of chromosomal segments occurred more frequently than losses. Overall, gains of chromosome 1, 3q, 5p, 7p, 8q, 9q, 10, 11p, 11q13, 12, 13, 14, 17, 18p, 20, Yp, and Xq were observed. The largest region affected by copy number loss was observed at chromosome 18q. Several of the observed genomic imbalances and their mapped genes were already associated with oral carcinoma and/or adverse prognosis, invasion, and metastasis in cancer. The most common rearrangements observed were translocations in the centromeric/near-centromeric regions. RARB, ESR1, and CADM1 genes were methylated and showed copy number losses, whereas TP73 and GATA5 presented with methylation and copy number gains. Thus, the current study presents a comprehensive characterization of the HSC-3 cell line; the use of this cell line may contribute to enriching the resources available for oral cancer research, especially for the testing of therapeutic agents.

Entities:  

Keywords:  HSC-3; chromosomal rearrangements; copy number alterations; methylation; oral cavity cell lines; translocation

Mesh:

Year:  2018        PMID: 29479029     DOI: 10.2334/josnusd.16-0811

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  3 in total

1.  (Cyto)genomic and epigenetic characterization of BICR 10 cell line and three new established primary human head and neck squamous cell carcinoma cultures.

Authors:  Ilda P Ribeiro; Joana M Rodrigues; Alexandra Mascarenhas; Vanessa Marques; Francisco Caramelo; Maria J Julião; Thomas Liehr; Joana B Melo; Isabel M Carreira
Journal:  Genes Genomics       Date:  2019-07-18       Impact factor: 1.839

2.  Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma.

Authors:  Ana Filipa Brito; Ana Margarida Abrantes; Ricardo Teixo; Ana Salomé Pires; Ana Cláudia Ribeiro; Rafael Fernandes Ferreira; Alexandra Fernandes; Tiago Puga; Mafalda Laranjo; Francisco Caramelo; Ilka Boin; Douglas M Jefferson; Ana Cristina Gonçalves; Ricardo Martins; Joana Rodrigues; Ilda Patrícia Ribeiro; Joana Barbosa De Melo; Ana Bela Sarmento-Ribeiro; Isabel Marques Carreira; Doroteia Souza; José Guilherme Tralhão; Maria Filomena Botelho
Journal:  Int J Oncol       Date:  2020-01-10       Impact factor: 5.650

3.  Knockdown of ectodysplasin-A receptor-associated adaptor protein exerts a tumor-suppressive effect in tongue squamous cell carcinoma cells.

Authors:  Meng Li; Yu-Ting Bai; Kun Han; Xiao-Dong Li; Jian Meng
Journal:  Exp Ther Med       Date:  2020-03-06       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.